AI assistant
Sending…
Aquestive Therapeutics, Inc. — Director's Dealing 2021
Feb 19, 2021
32552_dirs_2021-02-19_ef3a5131-49cc-4d38-9ddf-6978d90db814.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2021-02-10
Reporting Person: Krop Julie (N/A)
More from Aquestive Therapeutics, Inc.
Annual Report
2026
Apr 24
Regulatory Filings
2026
Mar 30
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Feb 26
Regulatory Filings
2026
Feb 2
Regulatory Filings
2026
Jan 21
Regulatory Filings
2026
Jan 9
Director's Dealing
2025
Dec 5
Director's Dealing
2025
Dec 4
Regulatory Filings
2025
Nov 17